- Poster presentation
- Open access
- Published:
Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
Critical Care volume 17, Article number: P515 (2013)
Methods
Data collection was conducted at three hospitals from 2008 to 2011. Patients with any active HM condition were matched with two control patients at two hospitals and with one control at Christie Hospital. Control patients had the same APACHE II (within 2 points) and admission diagnosis, but no HM. Readmissions and planned surgical cases were excluded.
Results
A total of 163 patients with HM were compared with 237 control patients. Seventy-four admissions with HM were identified at two hospitals, and each was matched with two control patients. Eighty-nine admissions with HM from Christie Hospital were identified. These were matched with 89 controls. Patients with HM spent significantly longer in hospital before ICU admission (Table 1). Unit and hospital mortality rates were not statistically different between patients with HM and without HM (Table 2).
Conclusion
Unit mortality of critically ill patients with HM was similar to those without HM. Hospital mortality in patients with HM was higher than those without HM, although not statistically significant. Severity of illness at presentation to critical care is the main determinant of outcome in patients with HM.
References
Hampshire PA, et al.: Crit Care. 2009, 13: R137. 10.1186/cc8016
Massion PB, et al.: Crit Care Med. 2002, 30: 2260-2270. 10.1097/00003246-200210000-00014
Author information
Authors and Affiliations
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Pugh, R., Hampshire, P. & Hajimichael, P. Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy. Crit Care 17 (Suppl 2), P515 (2013). https://doi.org/10.1186/cc12453
Published:
DOI: https://doi.org/10.1186/cc12453